Syntax Stratified MidCap ETF Rating $44.16 +0.12 (+0.27%) As of 09/27/2024 Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Syntax Stratified MidCap ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SMDY Aggregate RatingModerate Buy 2.53Holdings in SMDY have an aggregate rating of Moderate Buy based on 593 analyst ratings issued in the past year covering 48 companies (32.2% of the portfolio).SMDY Aggregate Price Target$44.16High Prediction$44.16Average Prediction$44.16Low Prediction$44.16Holdings in SMDY have an aggregate price target of $44.16 and a range of $44.16 to $44.16 covering 48 companies (32.2% of the portfolio).SMDY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy32 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Syntax Stratified MidCap ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 48 SMDY Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.82%SMGScotts Miracle-Gro$71.11+1.2%4.4531 of 5 stars2.29$75.83 6.6%7Upcoming Earnings1.64%COTYCoty$7.29+2.0%4.767 of 5 stars2.53$11.24 54.2%171.37%DOCSDoximity$55.52+3.3%3.1266 of 5 stars2.40$53.12 -4.3%20Positive News1.35%CIENCiena$88.77+4.7%4.6337 of 5 stars2.54$77.00 -13.3%131.28%FYBRFrontier Communications Parent$35.74+0.3%0.3642 of 5 stars2.17$35.31 -1.2%121.28%LITELumentum$97.45+3.2%3.3948 of 5 stars2.62$81.92 -15.9%13News Coverage1.24%HRHealthcare Realty Trust$16.91+2.6%3.4644 of 5 stars1.71$17.14 1.4%7Positive News1.18%IRDMIridium Communications$29.33+4.2%4.8364 of 5 stars2.75$41.00 39.8%40.97%ZDZiff Davis$55.50+1.0%4.2051 of 5 stars2.57$69.71 25.6%7Positive News0.83%DTDynatrace$53.24+3.8%4.9346 of 5 stars2.68$61.68 15.9%250.70%OHIOmega Healthcare Investors$37.68+0.8%3.4247 of 5 stars2.55$41.10 9.1%11High Trading Volume0.68%SBRASabra Health Care REIT$17.05+0.6%2.7871 of 5 stars2.78$19.13 12.2%90.68%QLYSQualys$139.74+2.0%1.7691 of 5 stars1.94$152.80 9.3%180.68%ACHCAcadia Healthcare$44.37+1.3%4.6791 of 5 stars2.78$70.22 58.3%90.67%LNWLight & Wonder$91.20+1.3%3.7749 of 5 stars2.71$108.50 19.0%140.67%THCTenet Healthcare$134.56+2.8%4.8188 of 5 stars2.88$165.00 22.6%170.63%ARMKAramark$38.51-1.7%4.901 of 5 stars2.82$42.59 10.6%110.57%TXRHTexas Roadhouse$182.04+1.7%4.1846 of 5 stars2.48$191.26 5.1%25Analyst UpgradeHigh Trading Volume0.56%WENWendy's$14.17-2.9%4.7541 of 5 stars2.21$19.71 39.1%19Analyst Forecast0.54%WINGWingstop$280.48+2.8%4.4839 of 5 stars2.74$368.16 31.3%19Analyst Upgrade0.52%UTHRUnited Therapeutics$367.97+2.5%4.926 of 5 stars2.73$378.36 2.8%15Positive NewsHigh Trading Volume0.51%DLBDolby Laboratories$81.46+0.2%4.6373 of 5 stars3.00$100.00 22.8%2Upcoming Earnings0.51%CRUSCirrus Logic$100.25-0.7%4.3707 of 5 stars2.71$132.50 32.2%70.51%HALOHalozyme Therapeutics$55.94+2.1%4.2879 of 5 stars2.60$60.89 8.8%10Short Interest ↑0.50%LADLithia Motors$353.06+0.2%4.4171 of 5 stars2.60$357.40 1.2%10Analyst RevisionHigh Trading Volume0.49%PAGPenske Automotive Group$163.05+1.6%3.5784 of 5 stars2.40$170.25 4.4%5Analyst Revision0.49%POSTPost$107.91+0.0%4.5617 of 5 stars2.86$123.57 14.5%70.49%EXELExelixis$36.43+0.6%4.6943 of 5 stars2.53$35.50 -2.6%190.48%AMKRAmkor Technology$26.72+3.1%4.9907 of 5 stars2.50$35.50 32.9%10High Trading Volume0.47%ILMNIllumina$141.31+3.4%4.5189 of 5 stars2.70$165.63 17.2%20Analyst Revision0.46%BMRNBioMarin Pharmaceutical$62.53+1.6%4.9978 of 5 stars2.74$94.20 50.6%23Analyst Revision0.46%ROIVRoivant Sciences$11.27+1.1%3.6563 of 5 stars2.88$17.93 59.1%80.45%KBHKB Home$66.95-1.4%4.7948 of 5 stars2.08$76.63 14.4%13Analyst Forecast0.45%ANAutoNation$184.93-0.2%1.5297 of 5 stars2.71$197.71 6.9%7Analyst RevisionNews Coverage0.45%TMHCTaylor Morrison Home$65.61-0.1%4.5294 of 5 stars3.00$84.00 28.0%8Positive News0.45%TOLToll Brothers$135.57+0.3%4.8198 of 5 stars2.53$156.64 15.5%150.45%WBSWebster Financial$60.30+1.1%4.9304 of 5 stars2.82$62.08 3.0%11Earnings ReportAnalyst ForecastNews Coverage0.45%SRPTSarepta Therapeutics$116.79-1.0%4.9641 of 5 stars2.91$178.71 53.0%22Analyst Revision0.44%PRGOPerrigo$24.44+2.5%4.9455 of 5 stars2.40$35.00 43.2%50.43%ASBAssociated Banc$25.62+1.8%4.9347 of 5 stars2.10$26.00 1.5%100.43%BRBRBellRing Brands$75.87+4.8%3.8009 of 5 stars2.80$76.67 1.1%15Positive News0.43%MTSIMACOM Technology Solutions$148.78+2.3%2.9232 of 5 stars2.70$128.00 -14.0%100.43%RGENRepligen$167.92+4.6%3.7258 of 5 stars2.62$185.20 10.3%13High Trading Volume0.42%CYTKCytokinetics$45.82+0.2%4.2914 of 5 stars2.80$83.64 82.5%15Analyst ForecastAnalyst RevisionNews Coverage0.42%GMEDGlobus Medical$92.33+1.7%4.4242 of 5 stars2.75$96.91 5.0%12Positive News0.42%CNOCNO Financial Group$39.23+1.2%4.3429 of 5 stars2.20$37.00 -5.7%5Positive News0.41%SLABSilicon Laboratories$136.24+1.1%1.0721 of 5 stars2.45$128.56 -5.6%11News Coverage0.41%SFStifel Financial$116.36+2.2%4.1147 of 5 stars2.25$107.14 -7.9%8 This page (NYSEARCA:SMDY) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syntax Stratified MidCap ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Syntax Stratified MidCap ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMDY Stock Alerts